Enobosarm
QUALITY
Veru Inc · Phase 2 · Completed · Enrollment 168
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Semaglutide and Enobosarm 3 mg QD by mouth (E3G) daily | n/r | n/r | n/r | n/r | n/r |
| Semaglutide and Enobosarm 6 mg QD by mouth (E6G) daily | n/r | n/r | n/r | n/r | n/r |
| GLP-1 receptor agonist and Placebo QD by mouth (PG) daily | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.